US Broker Ratings

AstraZeneca PLC (AZN)

⚠️ No article content returned.

..

Viatris Inc. (VTRS) Stock Analysis: Navigating a Complex Healthcare Landscape with Potential Value Play

As investors continue to navigate the ever-evolving healthcare sector, Viatris Inc. (NASDAQ: VTRS) emerges as an intriguing player in the market. With a market capitalization of $16.83 billion, Viatris is..

Charles River Laboratories (CRL) Stock Analysis: Exploring Its 14% Upside Potential

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a prominent player in the healthcare sector, specializing in diagnostics and research. Headquartered in Wilmington, Massachusetts, the company plays a crucial..

ResMed Inc. (RMD) Stock Analysis: Exploring a 9.51% Potential Upside in the Healthcare Sector

Investors keen on the healthcare sector have likely noticed ResMed Inc. (NYSE: RMD), a leading player in medical instruments and supplies. With a market capitalization of $39.65 billion, ResMed stands..

DexCom, Inc. (DXCM) Investor Outlook: Analyzing a 21.76% Potential Upside in the Medical Device Market

DexCom, Inc. (DXCM), a leading player in the healthcare sector specializing in medical devices, is making waves among investors for its innovative continuous glucose monitoring (CGM) systems. As a company..

DaVita Inc. (DVA) Investor Outlook: Analyzing the Healthcare Leader with a 7.73% Upside Potential

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specializes in providing kidney dialysis services across the United States. With a market capitalization of $9.41 billion, DaVita has..

Haleon plc (HLN) Stock Analysis: Exploring the 7.67% Potential Upside for Investors

Haleon plc (HLN) presents an intriguing opportunity for investors seeking exposure in the healthcare sector, particularly in the specialty and generic drug manufacturing industry. With a market capitalization of $48.9..

Incyte Corporation (INCY) Stock Analysis: Evaluating Growth Prospects Amid a Promising Pipeline in the Biotechnology Sector

Incyte Corporation (NASDAQ: INCY) is a renowned player in the biotechnology sector, offering innovative solutions through its diverse portfolio of therapeutics. With a market capitalization of $21.28 billion, the company..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 14.55% Potential Upside for Investors

Universal Health Services, Inc. (NYSE: UHS) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $13.91 billion, UHS..

Illumina, Inc. (ILMN) Stock Analysis: Navigating a 14.43% Potential Upside Amid Market Volatility

Illumina, Inc. (ILMN), a leading player in the healthcare sector specializing in diagnostics and research, is currently trading at $119.72. With a market capitalization of $18.4 billion, the company is..

Veeva Systems Inc. (VEEV) Stock Analysis: Unveiling a 68% Upside Potential for Savvy Investors

Investors eyeing opportunities in the healthcare technology sector should closely examine Veeva Systems Inc. (NYSE: VEEV), a prominent player offering cloud-based software solutions for the life sciences industry. Headquartered in..

Moderna, Inc. (MRNA) Stock Report: Navigating Biotech Challenges with Strategic Collaborations

Moderna, Inc. (NASDAQ: MRNA) has been a significant player in the biotechnology sector, especially renowned for its revolutionary mRNA technology. Headquartered in Cambridge, Massachusetts, the company has gained global recognition..

Humana Inc. (HUM) Stock Analysis: Evaluating 45.90% Potential Upside for Investors

As a formidable player in the healthcare plans industry, Humana Inc. (NYSE: HUM) offers intriguing prospects for investors seeking exposure to the healthcare sector. With a market capitalization of $23.33..

Stryker Corporation (SYK) Stock Analysis: Exploring an 18.45% Potential Upside in the Dynamic Medical Devices Sector

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector, particularly within the medical devices industry, presents a compelling case for investors looking to tap into a robust market with..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating Growth Potential and Market Position

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a formidable entity in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $15.27 billion, Medpace has..

Abbott Laboratories (ABT) Stock Analysis: A 20% Potential Upside and Robust Analyst Confidence

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector with a market capitalization of $192.9 billion, is capturing investor attention with a compelling growth narrative. Known for its diversified..

Globus Medical, Inc. (GMED) Stock Analysis: A 22% Upside Awaits in the Thriving Medical Devices Sector

Globus Medical, Inc. (NYSE: GMED) stands out in the healthcare sector, specifically within the dynamic field of medical devices. With a robust market capitalization of $11.86 billion, Globus Medical has..

Quest Diagnostics (DGX) Investor Outlook: A Healthcare Giant with 4.51% Potential Upside

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the Healthcare sector, operates within the Diagnostics & Research industry. With a market capitalization of $21.33 billion, Quest Diagnostics stands as..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 19.93% Upside Potential in the Animal Health Leader

Individual investors seeking to diversify their portfolios with a robust player in the healthcare sector may find Zoetis Inc. (NYSE: ZTS) a compelling option. As a leader in the animal..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating Potential Upside Amidst Healthcare Innovation

For individual investors seeking exposure to the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) presents a compelling opportunity, underscored by its robust market position and forward-looking growth potential. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds